Ruthenium complexes of 1,4-diazabutadiene ligands with a cis-RuCl2 moiety for catalytic acceptorless dehydrogenation of alcohols: DFT evidence of chemically non-innocent ligand participation

The acceptorless dehydrogenative coupling (ADC) of primary alcohols to esters by diazabutadiene-coordinated ruthenium compounds is reported. Treatment of cis-Ru(dmso)4Cl2 in acetone at 56 °C with different 1,4-diazabutadienes [p-XC6H4N[double bond, length as m-dash]C(H)(H)C[double bond, length as m-dash]NC6H4X-p; X = H, CH3, OCH3, and Cl; abbreviated as DAB-X], gives trans-Ru[κ2-N,N-DAB-X]2Cl2 as the kinetic product of substitution. Heating these products in o-xylene at 144 °C gives the thermodynamically favored cis-Ru[κ2-N,N-DAB-X]2Cl2 isomers. Electronic structure calculations confirm the greater stability of the cis diastereomer. The molecular structures for each pair of geometric isomers have been determined by X-ray diffraction analyses. Cyclic voltammetry experiments on the complexes show an oxidative response and a reductive response within 0.50 to 0.93 V and -0.76 to -1.24 V vs. SCE respectively. The cis-Ru[κ2-N,N-DAB-X]2Cl2 complexes function as catalyst precursors for the acceptorless dehydrogenative coupling of primary alcohols to H2 and homo- and cross-coupled esters. When 1,4-butanediol and 1,5-pentanediol are employed as substrates, lactones and hydroxyaldehydes are produced as the major dehydrogenation products, while secondary alcohols afforded ketones in excellent yields. The mechanism for the dehydrogenation of benzyl alcohol to benzyl benzoate and H2 using cis-Ru[κ2-N,N-DAB-H]2Cl2 (cis-1) as a catalyst precursor was investigated by DFT calculations. The data support a catalytic cycle that involves the four-coordinate species Ru[κ2-N,N-DAB-H][κ1-N-DAB-H](κ1-OCH2Ph) whose protonated κ1-diazabutadiene moiety functions as a chemically non-innocent ligand that facilitates a β-hydrogen elimination from the κ1-O-benzoxide ligand to give the corresponding hydride HRu[κ2-N,N-DAB-H][κ1-N-DAB-H](κ2-O,C-benzaldehyde). H2 production follows a Noyori-type elimination to give (H2)Ru[κ2-N,N-DAB-H][κ1-N-DAB-H](κ1-O-benzaldehyde) as an intermediate in the catalytic cycle.

An organometallic catalase mimic with exceptional activity, H2O2 stability, and catalase/peroxidase selectivity

Manganese-porphyrin and -salen redox therapeutics catalyze redox reactions involving O2˙-, H2O2, and other reactive oxygen species, thereby modulating cellular redox states. Many of these complexes perform catalase reactions via high-valent Mn-oxo or -hydroxo intermediates that oxidize H2O2 to O2, but these intermediates can also oxidize other molecules (e.g., thiols), which is peroxidase reactivity. Whether catalase or peroxidase reactivity predominates depends on the metal-ligand set and the local environment, complicating predictions of what therapeutic effects (e.g., promoting vs. suppressing apoptosis) a complex might produce in a given disease. We recently reported an organoruthenium complex (Ru1) that catalyzes ABTS˙- reduction to ABTS2- with H2O2 as the terminal reductant. Given that H2O2 is thermodynamically a stronger oxidant than ABTS˙-, we reasoned that the intermediate that reduced ABTS˙- would also be able to reduce H2O2 to H2O. Herein we demonstrate Ru1-catalyzed H2O2 disproportionation into O2 and H2O, exhibiting an 8,580-fold faster catalase TOF vs. peroxidase TOF, which is 89.2-fold greater than the highest value reported for a Mn-porphyin or -salen complex. Furthermore, Ru1 was 120-fold more stable to H2O2 than the best MnSOD mimic (TON = 4000 vs. 33.4) Mechanistic studies provide evidence that the mechanism for Ru1-catalyzed H2O2 disproportionation is conserved with the mechanism for ABTS˙- reduction. Therapeutic effects of redox catalysts can be predicted with greater accuracy for catalysts that exhibit exclusively catalase activity, thereby facilitating the development of future redox therapeutic strategies for diseases.

Glucose-oxidase like catalytic mechanism of noble metal nanozymes

Au nanoparticles (NPs) have been found to be excellent glucose oxidase mimics, while the catalytic processes have rarely been studied. Here, we reveal that the process of glucose oxidation catalyzed by Au NPs is as the same as that of natural glucose oxidase, namely, a two-step reaction including the dehydrogenation of glucose and the subsequent reduction of O₂ to H₂O₂ by two electrons. Pt, Pd, Ru, Rh, and Ir NPs can also catalyze the dehydrogenation of glucose, except that O₂ is preferably reduced to H₂O. By the electron transfer feature of noble metal NPs, we overcame the limitation that H₂O₂ must be produced in the traditional two-step glucose assay and realize the rapid colorimetric detections of glucose. Inspired by the electron transport pathway in the catalytic process of natural enzymes, noble metal NPs have also been found to mimic various enzymatic electron transfer reactions including cytochrome c, coenzymes as well as nitrobenzene reductions.

Novel CdFe Bimetallic Complex-Derived Ultrasmall Fe- and N-Codoped Carbon as a Highly Efficient Oxygen Reduction Catalyst

During the development of oxygen reduction reaction electrocatalysts, transition-metal nanoparticles embedded in N-doped graphene have attracted increasing attention owing to their low-priced, minimal environmental impact, and satisfying performance. In this study, a new organic-cadmium (Cd) complex formed through Cd²⁺ coordination with p-phenylenediamine (PPD) was used to synthesize highly active Fe-embedded N-doped carbon catalysts for the first time. It is significant that with the decreasing molar ratio of Cd/Fe, an obvious microstructure evolution was observed in Cd-Fe-PPD from diamond-like blocks to thick flakes, and further bloomed into flowerlike shapes with ultrathin petals and then eventually exhibited large block starfish-like shapes. After carbonization, Cd was removed, slack and porous N-doped carbon was formed, and Fe was assembled in the N-doped carbon. Similar phenomenon was also observed in Co-PPD. The optimized Fe/NPC-2 material featuring uniform and well-dispersed 3-5 nm Fe nanoparticles embedded in two-dimensional ultrathin carbon nanosheets delivered excellent electrocatalytic performance ( E_onset: 0.96 V vs reversible hydrogen electrode (RHE), E_1/2: 0.84 V vs RHE), which is very close to those of commercial platinum on carbon (Pt/C) ( E_onset: 0.95 V vs RHE, E_1/2: 0.84 V vs RHE), and its methanol tolerance and durability also surpass those of Pt/C.

Hydrogen peroxide as a hydride donor and reductant under biologically relevant conditions

Some ruthenium-hydride complexes react with O2 to yield H2O2, therefore the principle of microscopic reversibility dictates that the reverse reaction is also possible, that H2O2 could transfer an H- to a Ru complex. Mechanistic evidence is presented, using the Ru-catalyzed ABTS˙- reduction reaction as a probe, which suggests that a Ru-H intermediate is formed via deinsertion of O2 from H2O2 following coordination to Ru. This demonstration that H2O2 can function as an H- donor and reductant under biologically-relevant conditions provides the proof-of-concept that H2O2 may function as a reductant in living systems, ranging from metalloenzyme-catalyzed reactions to cellular redox homeostasis, and that H2O2 may be viable as an environmentally-friendly reductant and H- source in green catalysis.

A new diphosphine-carbonyl complex of ruthenium: an efficient precursor for C–C and C–N bond coupling catalysis

Reaction of 1,2-bis(diphenylphosphino)benzene (dppbz) with [{Ru(CO)₂Cl₂}_n] affords [Ru(dppbz)(CO)₂Cl₂], which serves as an excellent pre-catalyst for Suzuki-type C–C coupling and Buchwald-type C–N coupling reactions.

NAD+ as a Hydride Donor and Reductant

Reduced nicotinamide adenine dinucleotide (NADH) can generate a ruthenium-hydride intermediate that catalyzes the reduction of O₂ to H₂O₂, which endows it with potent anticancer properties. A catalyst that could access a Ru-H intermediate using oxidized nicotinamide adenine dinucleotide (NAD⁺) as the H^- source, however, could draw upon a supply of reducing equivalents 1000-fold more abundant than NADH, which would enable significantly greater H₂O₂ production. Herein, it is demonstrated, using the reduction of ABTS^•- to ABTS^2-, that NAD⁺ can function as a reductant. Mechanistic evidence is presented that suggests a Ru-H intermediate is formed via β-hydride elimination from a ribose subunit in NAD⁺. The insight gained from the heretofore unknown ability of NAD⁺ to function as a reductant and H^- donor may lead to undiscovered biological carbohydrate oxidation pathways and new chemotherapeutic strategies.